Polyarteritis Nodosa: Clinical Trials

22 trials for Polyarteritis Nodosa, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 5 recruiting, 5 unknown, 1 terminated. 4 Phase 2, 2 Phase 4, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Terminated 1, Unknown 1
Phase 42Completed 1, Unknown 1
Not applicable1Unknown 1
Phase 31Completed 1

Follow Polyarteritis Nodosa: new trials by email Literature Review of Polyarteritis Nodosa trials Research Report on Polyarteritis Nodosa

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis
Rituximab, Infliximab, Tocilizumab - Giant Cell Arteritis, Takayasu Arteritis
Phase 2TerminatedCambridge University Hospitals NHS Foundation Trust222021-07-142025-06-17
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
Naltrexone Hydrochloride, Placebo Comparator - Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS)
Phase 2CompletedUniversity of Pennsylvania602019-02-042026-01-22
Journey of Patients With Vasculitis From First Symptom to Diagnosis
Online Questionnaire - Vasculitis, Systemic Vasculitis
CompletedUniversity of Pennsylvania4562018-01-112018-06-06
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Cryoglobulinemic Vasculitis (CV), Drug-induced Vasculitis
RecruitingPeter Merkel502017-01-012026-01-22
VCRC Tissue Repository
Aortitis, Cutaneous Vasculitis
RecruitingUniversity of Pennsylvania10002016-11-012026-01-22
Vasculitis Pregnancy Registry
Online questionnaires - Vasculitis, Behcet's Disease
RecruitingUniversity of Pennsylvania1002015-11-012026-01-23
Impact of Vasculitis on Employment and Income
online questionnaire - Vasculitis, Systemic Vasculitis
CompletedUniversity of South Florida4262015-06-012016-01-28
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Takayasu's Arteritis, Giant Cell Arteritis
RecruitingNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)40002014-09-292026-10-22
VCRC Patient Contact Registry Patient-Reported Data Validation Study
Behcet's Disease, Churg-Strauss Syndrome
CompletedUniversity of South Florida1982014-05-012019-10-16
Pediatric Vasculitis Initiative
Wegeners Granulomatosis (Granulomatosis With Polyangiitis), Microscopic Polyangiitis
UnknownUniversity of British Columbia16002013-01-012023-11-30
Educational Needs of Patients With Systemic Vasculitis
Behcet's Disease, Churg-Strauss Syndrome
CompletedUniversity of South Florida3862012-03-012014-07-15
Vasculitis Illness Perception (VIP) Study
Wegener Granulomatosis, Microscopic Polyangiitis
CompletedUniversity of South Florida7072011-10-012014-07-15
Reproductive Health in Men and Women With Vasculitis
Giant Cell Arteritis, Takayasu's Arteritis
CompletedUniversity of South Florida4672011-02-012014-06-26
American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
Wegener's Granulomatosis, Microscopic Polyangiitis
UnknownUniversity of Oxford35882011-01-012016-08-19
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
RecruitingUniversity of Pennsylvania10002010-10-012026-01-22
Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
corticosteroid and azathioprine, corticosteroid and placebo - MPA, PAN or EGPA With FFS=0
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1142008-05-012025-09-12
Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa
Polyarteritis Nodosa
CompletedUniversity of Pennsylvania1072006-04-012022-07-12
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
prednisone, methylprednisolone,cyclophosphamides, Cyclophosphamide, Azathioprine,prednisone,methylprednisolone, Mycophenolate mofetil,methotrexate - Vasculitis, Wegener's Granulomatosis
Phase 4CompletedAssistance Publique - Hôpitaux de Paris1082005-07-012011-09-12
Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
anti-thymocyte globulin, cyclophosphamide, cyclosporine - Purpura, Schoenlein-Henoch, Graft Versus Host Disease
Not applicableUnknownFairview University Medical Center102000-03-012005-06-24
CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
azathioprine, cyclophosphamide - Polyarteritis Nodosa, Microscopic Polyangiitis
Phase 4UnknownHospices Civils de Lyon1241996-07-012006-11-16

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Microscopic Polyangiitis (17)  ·  Churg-Strauss Syndrome (16)  ·  Granulomatosis with Polyangiitis (16)  ·  Takayasu Arteritis (15)  ·  Giant Cell Arteritis (13)  ·  Vasculitis (12)  ·  IgA Vasculitis (10)  ·  Behcet Syndrome (7)  ·  Vasculitis, Central Nervous System (7)  ·  Cryoglobulinemia, Familial Mixed (5)  ·  Systemic Vasculitis (4)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2)  ·  Polychondritis, Relapsing (2)  ·  Anemia, Hemolytic, Autoimmune (1)

Broader conditions

Arteritis (22)  ·  Cardiovascular Diseases (22)  ·  Skin Diseases (22)  ·  Skin and Connective Tissue Diseases (22)  ·  Vascular Diseases (22)  ·  Skin Diseases, Vascular (21)  ·  Autoimmune Diseases (20)  ·  Brain Diseases (20)  ·  Central Nervous System Diseases (20)  ·  Cerebrovascular Disorders (20)  ·  Nervous System Diseases (20)  ·  Immune System Diseases (19)  ·  Hemic and Lymphatic Diseases (18)  ·  Systemic Vasculitis (18)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (17)

Interventions

Cyclophosphamide (4)  ·  Azathioprine (3)  ·  Methotrexate (2)  ·  Methylprednisolone (2)  ·  Prednisone (2)  ·  Adrenal Cortex Hormones (1)  ·  Antilymphocyte Serum (1)  ·  Cyclosporine (1)  ·  Filgrastim (1)  ·  Infliximab (1)  ·  Lamivudine (1)  ·  Mycophenolic Acid (1)  ·  Naltrexone (1)  ·  Rituximab (1)  ·  tocilizumab (1)

Sponsors

University of Pennsylvania (6)  ·  University of South Florida (5)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Fairview University Medical Center (1)  ·  Hospices Civils de Lyon (1)  ·  National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Peter Merkel (1)  ·  University of British Columbia (1)  ·  University of Oxford (1)  ·  University of Parma (1)

Countries

United States (17)  ·  Canada (7)  ·  France (3)  ·  United Kingdom (3)  ·  Denmark (2)  ·  Germany (2)  ·  India (2)  ·  Italy (2)  ·  Switzerland (2)  ·  Turkey (Türkiye) (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  China (1)

Top investigators

Peter A. Merkel, MD, MPH (5)  ·  Peter A Merkel, MD, MPH (4)  ·  Amanda M. Terry, MA (3)  ·  Megan Clowse, MD, MPH (2)  ·  Peter C. Grayson, MD (2)  ·  Peter Merkel, MD, MPH (2)  ·  Antoine Sreih, MD (1)  ·  Arne Slungaard (1)  ·  Carlo Buzio, MD (1)  ·  Christian Pagnoux, MD, MPH, MSc (1)  ·  Colin Ross, PhD (1)  ·  David Cabral, MBBS (1)  ·  David Jayne (1)  ·  Dirk Foell, MD (1)  ·  Janice Mooney, M.Sc. (1)

Results publications

PMID 25153486, PMID 25693055, PMID 27940595, PMID 28678392, PMID 29016646, PMID 31056661, PMID 31649025, PMID 31785185, PMID 33544969, PMID 35612893, PMID 38825350, PMID 38825354

NIH funding

U54AR057319 (4)